SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-010030
Filing Date
2018-05-15
Accepted
2018-05-15 16:50:42
Documents
55
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tlcc20180331_10q.htm 10-Q 544227
2 EXHIBIT 31.1 ex_113833.htm EX-31.1 12762
3 EXHIBIT 32.1 ex_113835.htm EX-32.1 6985
  Complete submission text file 0001437749-18-010030.txt   4426110

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tlcc-20180331.xml EX-101.INS 898837
5 XBRL TAXONOMY EXTENSION SCHEMA tlcc-20180331.xsd EX-101.SCH 55872
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlcc-20180331_cal.xml EX-101.CAL 36978
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlcc-20180331_def.xml EX-101.DEF 349368
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlcc-20180331_lab.xml EX-101.LAB 301928
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlcc-20180331_pre.xml EX-101.PRE 371043
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 18837385
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1